AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest

Blocking mitotic progression has been proposed as an attractive therapeutic strategy to impair proliferation of tumour cells. However, how cells survive during prolonged mitotic arrest is not well understood. We show here that survival during mitotic arrest is affected by the special energetic requi...

Full description

Saved in:
Bibliographic Details
Published inNature cell biology Vol. 17; no. 10; pp. 1304 - 1316
Main Authors Doménech, Elena, Maestre, Carolina, Esteban-Martínez, Lorena, Partida, David, Pascual, Rosa, Fernández-Miranda, Gonzalo, Seco, Esther, Campos-Olivas, Ramón, Pérez, Manuel, Megias, Diego, Allen, Katherine, López, Miguel, Saha, Asish K., Velasco, Guillermo, Rial, Eduardo, Méndez, Raúl, Boya, Patricia, Salazar-Roa, María, Malumbres, Marcos
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.10.2015
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Blocking mitotic progression has been proposed as an attractive therapeutic strategy to impair proliferation of tumour cells. However, how cells survive during prolonged mitotic arrest is not well understood. We show here that survival during mitotic arrest is affected by the special energetic requirements of mitotic cells. Prolonged mitotic arrest results in mitophagy-dependent loss of mitochondria, accompanied by reduced ATP levels and the activation of AMPK. Oxidative respiration is replaced by glycolysis owing to AMPK-dependent phosphorylation of PFKFB3 and increased production of this protein as a consequence of mitotic-specific translational activation of its mRNA. Induction of autophagy or inhibition of AMPK or PFKFB3 results in enhanced cell death in mitosis and improves the anti-tumoral efficiency of microtubule poisons in breast cancer cells. Thus, survival of mitotic-arrested cells is limited by their metabolic requirements, a feature with potential implications in cancer therapies aimed to impair mitosis or metabolism in tumour cells. Malumbres and colleagues reveal that mitotic arrest is accompanied by reduced mitochondrial mass and oxidative respiration resulting in activation of AMPK and induction of glycolysis to promote cell survival.
ISSN:1465-7392
1476-4679
DOI:10.1038/ncb3231